Okupe Oluyemi 4
4 · Hims & Hers Health, Inc. · Filed Feb 4, 2026
Research Summary
AI-generated summary of this filing
Hims & Hers (HIMS) CFO Okupe Oluyemi Sells Shares After Option Exercise
What Happened
Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, exercised stock options and sold the resulting 5,262 shares. The option exercise recorded an acquisition cost of $5.01 per share (total $26,363), and the same 5,262 shares were sold in the open market at an average weighted price of $26.44 per share for gross proceeds of about $139,108. The transactions were reported on a Form 4 filed Feb 4, 2026 covering activity on Feb 3, 2026.
Key Details
- Transaction date: February 3, 2026 (Form 4 filed Feb 4, 2026)
- Exercise (code M): 5,262 shares acquired at $5.01 each = $26,363
- Sale (code S): 5,262 shares sold at an average $26.44 each = $139,108 (shares sold in range $26.35–$26.56)
- A derivative conversion line shows 5,262 shares disposed at $0.00 (reporting the exercised/converted derivative)
- Sales were effected under a Rule 10b5‑1 trading plan adopted May 21, 2025 (footnote F1)
- Shares owned after the transaction: not specified in the provided excerpt
- Filing appears timely (transaction on 2/3/2026; Form 4 filed 2/4/2026)
Context
The filing shows an option exercise followed by an immediate sale of the resulting shares — a common pattern when insiders exercise options and then sell shares to cover costs or diversify. The reported use of a 10b5‑1 plan indicates the sales were prearranged under an established trading plan. Footnote F3 notes the underlying options vest monthly over a four‑year schedule; footnote F2 provides the sale price range and offers to provide per‑price breakdowns on request.
Insider Transaction Report
- Exercise/Conversion
Class A Common Stock
[F1]2026-02-03$5.01/sh+5,262$26,363→ 96,879 total - Sale
Class A Common Stock
[F2]2026-02-03$26.44/sh−5,262$139,108→ 91,617 total - Exercise/Conversion
Stock Option (right to buy)
[F1][F3]2026-02-03−5,262→ 144,051 totalExercise: $5.01Exp: 2032-02-23→ Class A Common Stock (5,262 underlying)
- 7,853(indirect: By Trust)
Class A Common Stock
Footnotes (3)
- [F1]The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.
- [F2]Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $26.35-$26.56. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]The Reporting Person received stock options to purchase shares of Class A Common Stock. The stock options vest over a 4-year period, with 1/48 of the shares vesting when the Reporting Person completes each month of continuous service, beginning March 24, 2022.